Additionally, in the PALOMA-3 trial, toxicity was increased in the elderly population, although it did not reach statistical significance.
← all excerpts
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort.
1
—
—